PRDS
Income statement / Annual
Last year (2022), Pardes Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Pardes Biosciences, Inc.'s net income was -$93.45 M.
See Pardes Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
| Research and Development
Expenses |
$70.35 M
|
$28.15 M
|
| General & Administrative
Expenses |
$29.47 M
|
$10.34 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$29.47 M
|
$10.34 M
|
| Other Expenses |
$0.00 |
$0.00 |
| Operating Expenses |
$99.82 M |
$38.49 M |
| Cost And Expenses |
$99.82 M |
$38.49 M |
| Interest Income |
$0.00 |
$0.00 |
| Interest Expense |
$3.18 M |
$30,000.00 |
| Depreciation &
Amortization |
-$1.06
|
$236,558.00
|
| EBITDA |
-$93.45 M
|
$38.49 M
|
| EBITDA Ratio |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
| Total Other
Income/Expenses Net |
$3.18 M
|
-$30,000.00
|
| Income Before Tax |
-$96.63 M |
-$38.52 M |
| Income Before Tax Ratio
|
0
|
0
|
| Income Tax Expense |
-$3.18 M |
$30,000.00 |
| Net Income |
-$93.45 M |
-$38.55 M |
| Net Income Ratio |
0 |
0 |
| EPS |
-1.61 |
-10.14 |
| EPS Diluted |
-1.61 |
-10.14 |
| Weighted Average Shares
Out |
$58.13 M
|
$3.80 M
|
| Weighted Average Shares
Out Diluted |
$58.13 M
|
$3.80 M
|
| Link |
|
|
